Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013).
An HJ, Lee B, Kim DH, Lee EK, Chung KW, Park MH, Jeong HO, Kim SM, Moon KM, Kim YR, Kim SJ, Yun HY, Chun P, Yu BP, Moon HR, Chung HY.
An HJ, et al. Among authors: kim dh, kim sj, kim yr, kim sm.
Oncotarget. 2017 Mar 7;8(10):16912-16924. doi: 10.18632/oncotarget.14818.
Oncotarget. 2017.
PMID: 28129657
Free PMC article.